Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2025-12-24 @ 5:58 PM
NCT ID:
NCT00378768
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed multiple myeloma
* Candidate for autologous or allogeneic stem cell transplantation within 1 to 3 months after study treatment
* Measurable disease, defined as serum monoclonal protein ≥ 1 g/dL OR urinary light chain excretion = 500 mg/24 hours
* No malignant CNS disease
PATIENT CHARACTERISTICS:
* Life expectancy ≥ 6 months
* Absolute neutrophil count ≥ 1,000/mm³
* Platelet count \> 50,000/mm³
* Creatinine ≤ 2 mg/dL
* Hepatic function ≤ 2 times upper limit of normal
* DLCO ≥ 50%
* No active infection
* No hypersensitivity to rabbit proteins
* No symptomatic hyperviscosity syndrome
* Negative pregnancy test
PRIOR CONCURRENT THERAPY:
* More than 28 days since prior chemotherapy, including prednisone (20 mg equivalent/day)
* No prior anti-thymocyte globulin
* No concurrent radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00378768
Study Brief:
Protocol Section:
NCT00378768